论文部分内容阅读
目前在临床工作中已广泛开展肿瘤标志物检测,但联合检测肿瘤标志物在肺癌的早期诊断、术后化疗及总体治疗效果的监控等方面尚属空白。本文观察148例肺癌患者癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角蛋白19(Cyk19)、癌抗原50(CA50)4项指标在早期诊断及治疗过程中的变
Currently in clinical work has been widely carried out tumor marker detection, but the joint detection of tumor markers in the early diagnosis of lung cancer, postoperative chemotherapy and the overall effect of treatment is still blank. This article observed 148 cases of lung cancer patients with carcinoembryonic antigen (CEA), neuron specific enolase (NSE), cytokeratin 19 (Cyk19), cancer antigen 50 (CA50) 4 indicators in the early diagnosis and treatment of change